Aleeto

DRUG3 trials

Sponsors

Beijing Tiantan Hospital

Conditions

Acute Ischemic StrokeAmyotrophic Lateral SclerosisMultiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy, MSA

Early Phase 1

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy

RecruitingNCT06765733

Beijing Tiantan HospitalMultiple System Atrophy, MSA, Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Start: 2025-05-31End: 2026-12-31Target: 20Updated: 2025-09-03

Phase 1

Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis

Beijing Tiantan HospitalAmyotrophic Lateral Sclerosis

Start: 2023-12-15End: 2024-10-30Target: 24Updated: 2023-12-26

Phase 2

Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial

RecruitingNCT06759753

Beijing Tiantan HospitalAcute Ischemic Stroke

Start: 2025-03-21End: 2026-01-31Target: 192Updated: 2025-09-03